Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker NBIX
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Sanjay Keswani Former Affiliate | NBIX Neurocrine Biosciences, Inc. | 53,614 | $9.0M | — | Nov 10, 2026 | — | Form 144 ↗ |
| Nov 2, 2026 | George Morrow Director | NBIX Neurocrine Biosciences, Inc. | 14,700 | $2.1M | 10b5-1 | Nov 2, 2026 | Form 4 ↗ 1 day later · 15,000 shares | Form 144 ↗ |
| Oct 30, 2026 | George Morrow Director | NBIX Neurocrine Biosciences, Inc. | 300 | $43.9K | 10b5-1 | Oct 30, 2026 | Form 4 ↗ 4 days later · 15,000 shares | Form 144 ↗ |
| Sep 14, 2026 | Matthew C Abernethy Officer | NBIX Neurocrine Biosciences, Inc. | 2,311 | $361.0K | 10b5-1 | Sep 14, 2026 | Form 4 ↗ 1 day later · 2,311 shares | Form 144 ↗ |
| Sep 14, 2026 | David Warren Boyer Officer | NBIX Neurocrine Biosciences, Inc. | 4,714 | $736.4K | 10b5-1 | Sep 14, 2026 | Form 4 ↗ 1 day later · 826 shares | Form 144 ↗ |
| Sep 9, 2026 | Eric Benevich Officer | NBIX Neurocrine Biosciences, Inc. | 2,154 | $334.2K | 10b5-1 | Sep 9, 2026 | Form 4 ↗ 1 day later · 2,154 shares | Form 144 ↗ |
| Jul 10, 2026 | Ingrid Delaet Officer | NBIX Neurocrine Biosciences, Inc. | 4,367 | $788.5K | 10b5-1 | Jul 10, 2026 | Form 4 ↗ 3 days later · 4,367 shares | Form 144 ↗ |
| Jul 9, 2026 | Darin Lippoldt Officer | NBIX Neurocrine Biosciences, Inc. | 10,000 | $1.8M | 10b5-1 | Jul 9, 2026 | Form 4 ↗ 4 days later · 10,000 shares | Form 144 ↗ |
| Jul 7, 2026 | Ingrid Delaet Officer | NBIX Neurocrine Biosciences, Inc. | 14,571 | $2.5M | 10b5-1 | Jul 7, 2026 | Form 4 ↗ 2 days later · 14,571 shares | Form 144 ↗ |
| Jun 29, 2026 | Darin Lippoldt Officer | NBIX Neurocrine Biosciences, Inc. | 9,800 | $1.7M | 10b5-1 | Jun 29, 2026 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Jun 26, 2026 | Darin Lippoldt Officer | NBIX Neurocrine Biosciences, Inc. | 200 | $32.8K | 10b5-1 | Jun 26, 2026 | Form 4 ↗ 4 days later · 10,000 shares | Form 144 ↗ |
| Jun 5, 2026 | Stephen Sherwin Director | NBIX Neurocrine Biosciences, Inc. | 25,000 | $4.2M | 10b5-1 | Jun 5, 2026 | Form 4 ↗ 4 days later · 25,000 shares | Form 144 ↗ |
| Jun 2, 2026 | Julie Cooke Officer | NBIX Neurocrine Biosciences, Inc. | 36,937 | $5.9M | 10b5-1 | Jun 2, 2026 | Form 4 ↗ 2 days later · 36,937 shares | Form 144 ↗ |
| Jun 1, 2026 | Jude Onyia Officer | NBIX Neurocrine Biosciences, Inc. | 11,000 | $1.7M | 10b5-1 | Jun 1, 2026 | Form 4 ↗ 1 day later · 11,000 shares | Form 144 ↗ |
| May 29, 2026 | Ingrid Delaet Officer | NBIX Neurocrine Biosciences, Inc. | 2,261 | $353.6K | 10b5-1 | May 29, 2026 | Form 4 ↗ 4 days later · 2,261 shares | Form 144 ↗ |
| May 27, 2026 | Jude Onyia Officer | NBIX Neurocrine Biosciences, Inc. | 11,000 | $1.7M | 10b5-1 | May 27, 2026 | Form 4 ↗ 2 days later · 11,000 shares | Form 144 ↗ |
| May 26, 2026 | David Warren Boyer Officer | NBIX Neurocrine Biosciences, Inc. | 3,888 | $609.2K | 10b5-1 | May 26, 2026 | Form 4 ↗ 2 days later · 3,888 shares | Form 144 ↗ |
| May 19, 2026 | Kevin Charles Gorman Director | NBIX Neurocrine Biosciences, Inc. | 245,088 | $38.5M | 10b5-1 | May 19, 2026 | Form 4 ↗ 2 days later · 245,088 shares | Form 144 ↗ |
| May 15, 2026 | Richard F Pops Director | NBIX Neurocrine Biosciences, Inc. | 15,000 | $2.4M | 10b5-1 | May 15, 2026 | Form 4 ↗ 3 days later · 15,000 shares | Form 144 ↗ |
| May 12, 2026 | Leslie V. Norwalk Director | NBIX Neurocrine Biosciences, Inc. | 6,310 | $1.0M | 10b5-1 | May 12, 2026 | Form 4 ↗ 2 days later · 3,810 shares | Form 144 ↗ |
| Jan 16, 2026 | Kyle Gano Officer | NBIX Neurocrine Biosciences, Inc. | 36,400 | $4.9M | 10b5-1 | Jan 16, 2026 | Form 4 ↗ 4 days later · 36,400 shares | Form 144 ↗ |
| Dec 15, 2025 | Leslie V. Norwalk Director | NBIX Neurocrine Biosciences, Inc. | 11,250 | $1.7M | 10b5-1 | Dec 15, 2025 | Form 4 ↗ 2 days later · 6,190 shares | Form 144 ↗ |
| Dec 8, 2025 | Darin Lippoldt Officer | NBIX Neurocrine Biosciences, Inc. | 4,376 | $680.5K | 10b5-1 | Dec 8, 2025 | Form 4 ↗ 2 days later · 4,376 shares | Form 144 ↗ |
| Dec 3, 2025 | Gary A Lyons Revocable Living U/A DTD 06/08/2012 Director | NBIX Neurocrine Biosciences, Inc. | 15,000 | $2.3M | 10b5-1 | Dec 3, 2025 | Form 4 ↗ 1 day later · 15,000 shares | Form 144 ↗ |
| Nov 28, 2025 | Eric Benevich Officer | NBIX Neurocrine Biosciences, Inc. | 5,970 | $904.9K | 10b5-1 | Nov 28, 2025 | Form 4 ↗ 4 days later · 5,970 shares | Form 144 ↗ |
| Nov 25, 2025 | George Morrow Director | NBIX Neurocrine Biosciences, Inc. | 15,000 | $2.1M | 10b5-1 | Nov 25, 2025 | Form 4 ↗ 1 day later · 15,000 shares | Form 144 ↗ |
| Nov 5, 2025 | William H. Rastetter Director | NBIX Neurocrine Biosciences, Inc. | 18,000 | $2.6M | 10b5-1 | Nov 5, 2025 | Form 4 ↗ 1 day later · 18,000 shares | Form 144 ↗ |
| Nov 5, 2025 | Kyle Gano Officer, Director | NBIX Neurocrine Biosciences, Inc. | 300 | $42.6K | 10b5-1 | Nov 4, 2025 | Form 4 ↗ 76 days later · 36,400 shares | Form 144 ↗ |
| Aug 7, 2025 | Kevin Charles Gorman Director | NBIX Neurocrine Biosciences, Inc. | 106,322 | $13.7M | 10b5-1 | Aug 7, 2025 | Form 4 ↗ 4 days later · 106,322 shares | Form 144 ↗ |
| Jul 10, 2025 | Ingrid Delaet Officer | NBIX Neurocrine Biosciences, Inc. | 457 | $61.0K | 10b5-1 | Jul 10, 2025 | Form 4 ↗ 1 day later · 457 shares | Form 144 ↗ |
| Jul 2, 2025 | Jude Onyia Officer | NBIX Neurocrine Biosciences, Inc. | 80,181 | $10.3M | 10b5-1 | Jul 2, 2025 | Form 4 ↗ 5 days later · 20,362 shares | Form 144 ↗ |
| May 27, 2025 | Kevin Charles Gorman Director | NBIX Neurocrine Biosciences, Inc. | 9,613 | $1.2M | 10b5-1 | May 27, 2025 | Form 4 ↗ 2 days later · 9,613 shares | Form 144 ↗ |
| May 5, 2025 | William H. Rastetter Officer | NBIX Neurocrine Biosciences, Inc. | 30,000 | $3.3M | 10b5-1 | May 5, 2025 | Form 4 ↗ 2 days later · 30,000 shares | Form 144 ↗ |
| Feb 14, 2025 | Eiry Wyn Roberts Officer | NBIX Neurocrine Biosciences, Inc. | 500 | $57.5K | — | Feb 14, 2025 | Form 4 ↗ same day · 2,218 shares | Form 144 ↗ |
| Feb 13, 2025 | Stephen A Sherwin Director | NBIX Neurocrine Biosciences, Inc. | 13,831 | $1.6M | 10b5-1 | Feb 13, 2025 | Form 4 ↗ 1 day later · 13,831 shares | Form 144 ↗ |
| Feb 13, 2025 | Matthew Abernethy Officer | NBIX Neurocrine Biosciences, Inc. | 1,352 | $158.4K | 10b5-1 | Feb 13, 2025 | Form 4 ↗ 1 day later · 2,558 shares | Form 144 ↗ |
| Feb 13, 2025 | Matthew C Abernethy Officer | NBIX Neurocrine Biosciences, Inc. | 1,206 | $141.3K | 10b5-1 | Feb 13, 2025 | Form 4 ↗ 1 day later · 2,558 shares | Form 144 ↗ |
| Feb 13, 2025 | Kevin Charles Gorman Director | NBIX Neurocrine Biosciences, Inc. | 3,012 | $352.9K | 10b5-1 | Feb 13, 2025 | Form 4 ↗ 1 day later · 5,844 shares | Form 144 ↗ |
| Feb 13, 2025 | Kyle W Gano Officer | NBIX Neurocrine Biosciences, Inc. | 1,206 | $141.3K | 10b5-1 | Feb 13, 2025 | Form 4 ↗ 1 day later · 2,558 shares | Form 144 ↗ |
| Feb 13, 2025 | Julie Smith Cooke Officer | NBIX Neurocrine Biosciences, Inc. | 755 | $88.5K | 10b5-1 | Feb 13, 2025 | Form 4 ↗ 1 day later · 1,551 shares | Form 144 ↗ |
| Feb 13, 2025 | Eric S Benevich Officer | NBIX Neurocrine Biosciences, Inc. | 1,056 | $123.7K | 10b5-1 | Feb 13, 2025 | Form 4 ↗ 1 day later · 2,154 shares | Form 144 ↗ |
| Feb 13, 2025 | Jude Onyia Officer | NBIX Neurocrine Biosciences, Inc. | 1,447 | $169.6K | 10b5-1 | Feb 13, 2025 | Form 4 ↗ 1 day later · 2,879 shares | Form 144 ↗ |
| Feb 13, 2025 | Ingrid Delaet Officer | NBIX Neurocrine Biosciences, Inc. | 755 | $88.5K | 10b5-1 | Feb 13, 2025 | Form 4 ↗ 1 day later · 1,471 shares | Form 144 ↗ |
| Feb 13, 2025 | David Warren Boyer Officer | NBIX Neurocrine Biosciences, Inc. | 830 | $97.3K | 10b5-1 | Feb 13, 2025 | Form 4 ↗ 1 day later · 1,785 shares | Form 144 ↗ |
| Feb 13, 2025 | Darin Lippoldt Officer | NBIX Neurocrine Biosciences, Inc. | 1,086 | $127.3K | 10b5-1 | Feb 13, 2025 | Form 4 ↗ 1 day later · 2,184 shares | Form 144 ↗ |
| Feb 13, 2025 | Eiry Wyn Roberts Officer | NBIX Neurocrine Biosciences, Inc. | 604 | $70.8K | 10b5-1 | Feb 13, 2025 | Form 4 ↗ 1 day later · 2,218 shares | Form 144 ↗ |
| Feb 13, 2025 | Eiry Roberts Officer | NBIX Neurocrine Biosciences, Inc. | 1,114 | $130.5K | 10b5-1 | Feb 13, 2025 | Form 4 ↗ 1 day later · 2,218 shares | Form 144 ↗ |
| Feb 13, 2025 | Darin Lippoldt Officer | NBIX Neurocrine Biosciences, Inc. | 1,098 | $128.7K | 10b5-1 | Feb 13, 2025 | Form 4 ↗ 1 day later · 2,184 shares | Form 144 ↗ |
| Feb 13, 2025 | Eric Benevich Officer | NBIX Neurocrine Biosciences, Inc. | 1,098 | $128.7K | 10b5-1 | Feb 13, 2025 | Form 4 ↗ 1 day later · 2,154 shares | Form 144 ↗ |
| Feb 13, 2025 | Jude Onyia Officer | NBIX Neurocrine Biosciences, Inc. | 1,432 | $167.8K | 10b5-1 | Feb 13, 2025 | Form 4 ↗ 1 day later · 2,879 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 8:21 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances